📰 New paper
Cost-utility analysis of early versus delayed endovascular intervention in critical limb-threatening ischemia patients with rest pain
By R. Vada (@speakingnerd), N. Malyar & @TomStargardt in the @VascularSVS Journal of Vascular Surgery: https://t.co/PYsUXEruql
How do SARS-CoV-2 reinfections impact long-term health outcomes? @patientled developed a survey to study this important question. Please take a few minutes to fill out this survey (available in multiple languages)👇🏽
https://t.co/pPzEgT8c96
I am proud that our paper that analyzes the impact on EU investments in research and medical device innovation (https://t.co/EAWCRLmvzM) is part of this special issue collection. Check the other papers which have a couple of insights from Covid-19 and the economy!
Loss of access to such funding sources like in 🇨🇭 (https://t.co/FWfoGGlWJh) and in 🇩🇪 reducing funding volumes (https://t.co/vRBOSxAWpD) may have adverse effects on the local knowledge production of new medical devices. (7/7)
What is the role of public funding in cardiovascular medical device innovation?
Check out this new evidence, part of @IQCE@hche, w. co-🖊️ @Katblankart@CINCHessen,
Short summary⬇️// Full paper➡️https://t.co/pzS05kqa5O // Code and data X ➡️https://t.co/gauMun4tG4 (1/7)
Don't know what to attend for @AOMconnect? Why not take a look at 🏆 papers of @AOM_HCM? Lots on team diversity, teamwork, physician / nursing discretion & safety. We will be up 19:15-21:00 CEST, Tue, 3 Aug, session info ⬇️
@ZJAyres been told this a few times at occasions where competitive assessments were at place: 95% times- their own insecurities & rest 5% - wise people told not to do it so insecure ones can feel safe ;)
happens to all. majority to females. unfortunately often by females